Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a new vaccine to treat acute myeloid leukaemia that has come back after a stem cell transplant (RFUSIN2-AML1)

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at a new vaccine made by altering people’s own donated leukaemia cells and injecting them back to trigger their immune system. You have the vaccine with the standard treatment of having white blood cells through a drip into a vein.

Recruitment start: 27 July 2009

Recruitment end: 9 August 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Pramila Krishnamurthy

Supported by

Experimental Cancer Medicine Centre (ECMC)

Guy's and St Thomas' NHS Foundation Trust

King's College London

Kings College Hospital NHS Foundation Trust

NIHR Biomedical Research Centres (BRCs) Award

Last reviewed: 21 Jun 2022

CRUK internal database number: 2578

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.